Serum HIV-1 RNA levels and time to development of AIDS in the multicenter hemophilia cohort study

被引:277
作者
OBrien, TR
Blattner, WA
Waters, D
Eyster, ME
Hilgartner, MW
Cohen, AR
Luban, N
Hatzakis, A
Aledort, LM
Rosenberg, PS
Miley, WJ
Kroner, BL
Goedert, JJ
机构
[1] PRI,FREDERICK,MD
[2] MILTON S HERSHEY MED CTR,HERSHEY,PA
[3] CORNELL UNIV,MED CTR,NEW YORK,NY 10021
[4] CHILDRENS HOSP PHILADELPHIA,PHILADELPHIA,PA 19104
[5] CHILDRENS HOSP,NATL MED CTR,WASHINGTON,DC 20010
[6] MT SINAI MED CTR,NEW YORK,NY 10029
[7] UNIV ATHENS,SCH MED,GR-11527 ATHENS,GREECE
[8] NCI,BIOSTAT BRANCH,ROCKVILLE,MD
[9] RES TRIANGLE INST,ROCKVILLE,MD
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1996年 / 276卷 / 02期
关键词
D O I
10.1001/jama.276.2.105
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective.-To determine if the long-term incidence of the acquired immunodeficiency syndrome (AIDS) is related to human immunodeficiency virus type 1 (HIV-1) RNA levels measured early in HIV-1 infection. Design.-Epidemiologic cohort study. Setting.-Five hemophilia treatment centers in the United States. Subjects.-A total of 165 subjects with hemophilia and HIV-1 infection (age at HIV-1 seroconversion, 1-66 years) followed from 1979 to 1995. Methods.-The HIV-1 RNA level was measured by polymerase chain reaction over a range of 200 to 1 million or more HIV-1 RNA copies/mL. in archived serum specimens collected 12 to 36 months (median, 27 months) after the estimated date of HIV-1 seroconversion. Kaplan-Meier methods were used to examine the risk of AIDS and proportional hazards models were used to estimate relative hazards. Results.-The HIV-1 RNA values were similar in subjects younger than 17 years at seroconversion (median, 5214 copies/mL) and those 18 to 34 years old (median, 4693 copies/mL), but higher in those 35 years or older (median, 12 069 copies/mL) (P=.02 compared with each younger group). At 10 years after seroconversion, the proportions of subjects with AIDS were 72% among subjects with 100 000 or more HIV-1 RNA copies/mL measured 12 to 36 months after HIV-1 seroconversion (n=9), 52% among subjects with 10 000 to 99 999 copies/mL (n=55), 22% among subjects with 1000 to 9999 copies/mL (n=82), and 0% among subjects with fewer than 1000 copies/mL (n=19) (P<.001). The age-adjusted relative hazard for AIDS for subjects with 10 000 or more copies/mL was 14.3 (95% confidence interval, 1.9-105.6) compared with subjects with fewer than 1000 copies/mL. Conclusions.-The HIV-1 RNA level during early chronic HIV-1 infection is a strong, age-independent predictor of clinical outcome; low revels define persons with a high probability of long-term AIDS-free survival.
引用
收藏
页码:105 / 110
页数:6
相关论文
共 28 条
[1]  
ARMITAGE P, 1971, STATISTICAL METHODS, P396
[2]  
COX DR, 1972, J R STAT SOC B, V34, P187
[3]   TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
DAAR, ES ;
MOUDGIL, T ;
MEYER, RD ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :961-964
[4]  
Dean A. G., 1990, EPI INFO VERSION 5 W
[5]   IS HIV THE CAUSE OF AIDS [J].
DUESBERG, PH .
LANCET, 1995, 346 (8986) :1371-1372
[6]   NATURAL-HISTORY OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTIONS IN HEMOPHILIACS - EFFECTS OF T-CELL SUBSETS, PLATELET COUNTS, AND AGE [J].
EYSTER, ME ;
GAIL, MH ;
BALLARD, JO ;
ALMONDHIRY, H ;
GOEDERT, JJ .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (01) :1-6
[7]   THE SAFETY AND EFFICACY OF ZIDOVUDINE (AZT) IN THE TREATMENT OF SUBJECTS WITH MILDLY SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV) INFECTION - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
FISCHL, MA ;
RICHMAN, DD ;
HANSEN, N ;
COLLIER, AC ;
CAREY, JT ;
PARA, MF ;
HARDY, WD ;
DOLIN, R ;
POWDERLY, WG ;
ALLAN, JD ;
WONG, B ;
MERIGAN, TC ;
MCAULIFFE, VJ ;
HYSLOP, NE ;
RHAME, FS ;
BALFOUR, HH ;
SPECTOR, SA ;
VOLBERDING, P ;
PETTINELLI, C ;
ANDERSON, J .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (10) :727-737
[8]  
FLETCHER MA, 1987, DIAGN CLIN IMMUNOL, V5, P69
[9]   A PROSPECTIVE-STUDY OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 INFECTION AND THE DEVELOPMENT OF AIDS IN SUBJECTS WITH HEMOPHILIA [J].
GOEDERT, JJ ;
KESSLER, CM ;
ALEDORT, LM ;
BIGGAR, RJ ;
ANDES, WA ;
WHITE, GC ;
DRUMMOND, JE ;
VAIDYA, K ;
MANN, DL ;
EYSTER, ME ;
RAGNI, MV ;
LEDERMAN, MM ;
COHEN, AR ;
BRAY, GL ;
ROSENBERG, PS ;
FRIEDMAN, RM ;
HILGARTNER, MW ;
BLATTNER, WA ;
KRONER, B ;
GAIL, MH .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (17) :1141-1148
[10]   RISKS OF IMMUNODEFICIENCY, AIDS, AND DEATH RELATED TO PURITY OF FACTOR-VIII CONCENTRATE [J].
GOEDERT, JJ ;
COHEN, AR ;
KESSLER, CM ;
EICHINGER, S ;
SEREMETIS, SV ;
RABKIN, CS ;
YELLIN, FJ ;
ROSENBERG, PS ;
ALEDORT, LM .
LANCET, 1994, 344 (8925) :791-792